Concepedia

Charles Locke

CL

Statistics

Publications

39

Citations

1.8K

H-Index

22

Active since

1984

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

AbbVie (United States)

Abbott (United States)

Cairo University

Charles Locke is an author at Abbott Fund specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1984–2021

39

Publications

39

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects

Jonathan Q. Purnell, Alberto Zambon, Robert H. Knopp et al. · AIDS · 2000 · 394 citations

, , +17

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

Danièle Ouellet, Ann Hsu, Jiang Qian et al. · British Journal of Clinical Pharmacology · 1998 · 175 citations · Full text

, , +10

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

Dag Nyholm, Per Odin, Anders Johansson et al. · The AAPS Journal · 2012 · 122 citations

, , +12

Are Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable?

Vicky A. Blakesley, Walid M. Awni, Charles Locke et al. · Thyroid · 2004 · 86 citations

, , +17

An exact confidence interval from untransformed data for the ratio of two formulation means

Charles Locke · Journal of Pharmacokinetics and Biopharmaceutics · 1984 · 85 citations

, , +10

1–5 of 39